ICAgen Company

ICAgen, a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.
Technology: Data-driven Technologies
Industry: PharmTech
Headquarters: Durham, North Carolina, United States
Founded Date: 1992
Estimated Revenue: $10M to $50M
Visit Website
InvestorsandPress@icagen.com
https://twitter.com/icagen_inc
Register and Claim Ownership